Skip to main content

Table 2 Baseline characteristics of the included studies

From: Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis

Study

Group

Age

Mean

(SD)

Sex

No. of Female/Male

Weight

Mean

(SD)

BMI

Mean

(SD)

SBP

Mean

(SD)

FBG

Mean

(SD)

Duration– yr.

Mean

(SD)

Smoker – no. (%)

Brasnyo et al.

Resveratrol

Placebo

57·9(7·9)

52.5(11.1)

NA

90.1(16.3)

105.3(16.7)

NA

140(12)

140(17)

7.9(2.21)

8.8(3.2)

NA

0(10)

0(9)

Bhatt et al.

Resveratrol

Placebo

56.67(8.91)

57.75(8.71)

16/12

20/9

64.78(9.25)

63.1(9.02)

24.66(3.57)

24.92(3.05)

139.71(16.10)

134.51(14.61)

11.82(3.58)

10.11(2.56)

7.57(4.56)

6.68(4.7)

6/28

6/29

Movahed et al.

Resveratrol

Placebo

52.45(6.18)

51.81(6.99)

17/16

16/17

74.26(11.39)

76.60(14.27)

27.05(3.13)

27.83(4.12)

129.03(14.91)

129.31(15.16)

9.76(2.76)

8.40(2.86)

5.81(1.53)

5.39(1.36)

7(21.9)

4.(12.9)

Goh et al.

Resveratrol

Placebo

55.8(7.3)

56.3(6.0)

NA

87.0(26.6)

68.3(13.7)

29.4(6.8)

24.4(3.6)

NA

11.8(2.9)

9.5(1.0)

9.4(5.3)

9.6(6.3)

1(10)

2(20)

Tome-Carneiro et al.

Resveratrol

Placebo

63(12)

58(10)

NA

84(11)

85(16)

31(5.1)

32(4.5)

130(16)

129(21)

8.39(3)

8.22(2)

NA

2(22)

8(36)

Bashmakov et al.

Resveratrol

Placebo

54.0(10.1)

59.8(6.6)

6/8

3/7

NA

28(3.5)

29(2.5)

NA

NA

15(6.9)

15.2(9.5)

3(21)

1(10)

Thazhath et al.

Resveratrol

Placebo

NA

NA

81.1(3.7)

81.1(4.3)

NA

NA

8.1(0.3)

8.2(0.3)

NA

NA

Timmers et al.

Resveratrol

Placebo

NA

NA

NA

NA

138(11.8)

141(11.7)

7.80(1.62)

7.70(1.70)

NA

NA

Javid et al.

Resveratrol

Placebo

49.1(7.4)

50.9(8.9)

16/5

18/4

73.8(10.2)

70.95(11)

29.3(4.9)

28.3(4.8)

NA

8.5(3.1)

9.4(3.0)

NA

NA

  1. BMI body mass index, SBP systolic blood pressure, FBG fasting blood glucose